GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Benzoate degradation via CoA ligation

pathways : Benzoate degradation via CoA ligation pathways:

Fullview (zoomIn)

Related Pathways to "Benzoate degradation via CoA ligation" content :


Related Genes to "Benzoate degradation via CoA ligation" content :

preload


Flag U.S.AEN | Flag FranceFR | Flag U.S.AUS | Flag GermanyDE | Flag PolandPL
Flag NetherlandsNL | Flag BelgiumBE | Flag UKUK | Flag BugariaBG

Kits Elisa; taq POLYMERASE

Search in Google:

google

Share this page:
share on twitter rss feedsfacebookgoogle gentaur



Quick order!
Enter catalog number :


Categories :

Gentaur; yes we can

Related products :

Catalog number Product name Quantity
C175670 Capecitabine Benzoate (mixture of 2’(3’)-benzoate isomers) C22H26FN3O7 CAS: 10 mg
2049-96-9 n-Pentyl benzoate n-Amyl benzoate 1g
136-60-7 Butyl benzoate n_Butyl benzoate ; Benz 1g
30-956 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
30-957 Autophagy is the major intracellular degradation system delivering cytoplasmic components to lysosomes, and it accounts for degradation of most long-lived proteins and some organelles. Cytoplasmic con 0.05 mg
orb60544 Rizatriptan Benzoate Rizatriptan Benzoate(Maxalt) is a 5-HT1 agonist triptan drug for the treatment of migraine headaches. For research use only. 10 mg
27-171 ERLIN2 plays an important role in the early steps of the endoplasmic reticulum-associated degradation (ERAD) pathway. It is involved in ITPR1 degradation by the ERAD pathway. 0.05 mg
31-050 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. It inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 w 0.05 mg
31-051 MDM4 inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. inhibits degradation of MDM2. It can reverse MDM2-targeted degradation of p53 whil 0.1 mg
5743-30-6 Calcium benzoate trihydrate Calcium benzoate trihy 1g
D0004 DNA Ligation Kit 1 Kit
F0661-150 fastLinky 5 Min DNA Ligation Kit 5x30 rxns
PR2302 Rapid DNA Ligation Kit 60
DS110 DNA Ligation Kit, Version 2 10x1kit
RC011 RBC Rapid Ligation Kit T4 Ligase (3U/mI)( 1 00m 1) Ligation Buffer A (200^1) Liqation Buffer B (200ul)
LB001 • Ligation Buffer 1.4 ml
K-7102 AccuRapid™ DNA Ligation Kit 150 ligations
LB001 Ligation Buffer 1.4 ml
F0661-030 fastLinky 5 Min DNA Ligation Kit 30 rxns x 5
PR2301 Rapid DNA Ligation Kit 30
LB001 Ligation Buffer 1.4 ml
PR2302 DNA Rapid Ligation Kit 60
PR2301 DNA Rapid Ligation Kit 30
VT203-02 pBS_T II Ligation Kit 60 µl
VT203-01 pBS_T II Ligation Kit 20 µl

Pathways :

WP1626: Benzoate degradation via CoA ligation
WP1627: Benzoate degradation via hydroxylation
WP101: Synthesis and Degradation of Ketone Bodies
WP1015: Synthesis and Degradation of Ketone Bodies
WP1079: Proteasome Degradation
WP1134: Synthesis and Degradation of Ketone Bodies
WP1196: Proteasome Degradation
WP1240: Proteasome Degradation
WP1451: Valine, leucine and isoleucine degradation
WP158: Proteasome Degradation
WP1612: 1,2-Dichloroethane degradation
WP1613: 1,4-Dichlorobenzene degradation
WP1614: 1- and 2-Methylnaphthalene degradation
WP1615: 3-Chloroacrylic acid degradation
WP1623: Atrazine degradation
WP1632: Biphenyl degradation
WP1633: Bisphenol A degradation
WP1636: Caprolactam degradation
WP1637: Carbazole degradation
WP1646: Ethylbenzene degradation
WP1649: Fluorene degradation
WP1650: Fluorobenzoate degradation
WP1654: gamma-Hexachlorocyclohexane degradation
WP1655: Geraniol degradation
WP1665: Limonene and pinene degradation

Related Genes :
[hbaA RPA0669] 4-hydroxybenzoate--CoA/benzoate--CoA ligase (EC 6.2.1.25) (EC 6.2.1.27) (4-hydroxybenzoyl-CoA synthetase)
[BSMT1 At3g11480 F24K9.15] Salicylate/benzoate carboxyl methyltransferase (Benzoate O-methyltransferase) (EC 2.1.1.273) (S-adenosyl-L-methionine:benzoic acid carboxyl methyltransferase) (S-adenosyl-L-methionine:salicylate acid carboxyl methyltransferase) (SABATH methyltransferase) (Salicylate carboxymethyltransferase) (EC 2.1.1.274)
[HRD1 DER3 YOL013C] ERAD-associated E3 ubiquitin-protein ligase HRD1 (EC 2.3.2.27) (HMG-CoA reductase degradation protein 1) (RING-type E3 ubiquitin transferase HRD1)
[bclA] Benzoate--CoA ligase (EC 6.2.1.25) (Benzoyl-CoA synthetase)
[HRD3 YLR207W] ERAD-associated E3 ubiquitin-protein ligase component HRD3 (HMG-CoA reductase degradation protein 3)
[tesA apeA pldC b0494 JW0483] Thioesterase 1/protease 1/lysophospholipase L1 (TAP) (Acyl-CoA thioesterase 1) (TESA) (EC 3.1.2.2) (Acyl-CoA thioesterase I) (Arylesterase) (EC 3.1.1.2) (Lysophospholipase L1) (EC 3.1.1.5) (Oleoyl-[acyl-carrier-protein] hydrolase) (EC 3.1.2.14) (Phospholipid degradation C) (Pldc) (Protease 1) (EC 3.4.21.-) (Protease I) (Thioesterase I/protease I) (TEP-I)
[tesA c0615] Thioesterase 1/protease 1/lysophospholipase L1 (TAP) (Acyl-CoA thioesterase 1) (TESA) (EC 3.1.2.2) (Acyl-CoA thioesterase I) (Arylesterase) (EC 3.1.1.2) (Lysophospholipase L1) (EC 3.1.1.5) (Oleoyl-[acyl-carrier-protein] hydrolase) (EC 3.1.2.14) (Phospholipid degradation C) (Pldc) (Protease 1) (EC 3.4.21.-) (Protease I) (Thioesterase I/protease I) (TEP-I)
[] 4-chlorobenzoate--CoA ligase (4-CBA:CoA ligase) (EC 6.2.1.33)
[ACSM1 BUCS1 LAE MACS1] Acyl-coenzyme A synthetase ACSM1, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 1) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1)
[NPL4 HRD4 YBR170C YBR1231] Nuclear protein localization protein 4 (HMG-CoA reductase degradation protein 4)
[bphA cyp53 cyp53A1] Benzoate 4-monooxygenase (EC 1.14.14.92) (Benzoate-para-hydroxylase) (BpH) (Cytochrome P450 53)
[ACSM2B ACSM2 HYST1046] Acyl-coenzyme A synthetase ACSM2B, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 2B) (Butyrate--CoA ligase 2B) (Butyryl-coenzyme A synthetase 2B) (Middle-chain acyl-CoA synthetase 2B) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A)
[DOA1 UFD3 ZZZ4 YKL213C] Protein DOA1 (Degradation of alpha protein 1) (Ubiquitin fusion degradation protein 3)
[Msed_0406] 4-hydroxybutyrate--CoA ligase 1 (EC 6.2.1.40) (Acetate--CoA ligase) (EC 6.2.1.1) (Butyrate--CoA ligase) (EC 6.2.1.2) (Propionate--CoA ligase) (EC 6.2.1.17)
[Msed_0394] 4-hydroxybutyrate--CoA ligase 2 (EC 6.2.1.40) (Acetate--CoA ligase) (EC 6.2.1.1) (Butyrate--CoA ligase) (EC 6.2.1.2) (Propionate--CoA ligase) (EC 6.2.1.17) (acyl-activating enzyme)
[RPN1 HRD2 NAS1 RPD1 YHR027C] 26S proteasome regulatory subunit RPN1 (HMG-CoA reductase degradation protein 2) (Proteasome non-ATPase subunit 1)
[Acsm1 Bucs1 Lae Macs1] Acyl-coenzyme A synthetase ACSM1, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 1) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1)
[GLYAT ACGNAT CAT GAT] Glycine N-acyltransferase (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase) (AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase) (EC 2.3.1.71) (HRP-1(CLP))
[VID24 GID4 YBR105C YBR0834] Vacuolar import and degradation protein 24 (Glucose-induced degradation protein 4)
[VID30 GID1 YGL227W] Vacuolar import and degradation protein 30 (Glucose-induced degradation protein 1)
[UFD1 UFD1L] Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1)
[AUH] Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)
[dmdB SPO2045] 3-methylmercaptopropionyl-CoA ligase (MMPA-CoA ligase) (EC 6.2.1.44) (Acyl-CoA ligase)
[fadB oldB b3846 JW3822] Fatty acid oxidation complex subunit alpha [Includes: Enoyl-CoA hydratase/Delta(3)-cis-Delta(2)-trans-enoyl-CoA isomerase/3-hydroxybutyryl-CoA epimerase (EC 4.2.1.17) (EC 5.1.2.3) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]
[Auh] Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding enoyl-CoA hydratase) (muAUH) (Itaconyl-CoA hydratase) (EC 4.2.1.56)
[fadB faoA] Fatty acid oxidation complex subunit alpha [Includes: Enoyl-CoA hydratase/Delta(3)-cis-Delta(2)-trans-enoyl-CoA isomerase/3-hydroxybutyryl-CoA epimerase (EC 4.2.1.17) (EC 5.1.2.3) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]
[MCCC2 MCCB] Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)
[glmU C3Y08_06150 DM48_4464] Bifunctional protein GlmU [Includes: Glucosamine-1-phosphate N-acetyltransferase (EC 2.3.1.157); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (N-acetylglucosamine-1-phosphate uridyltransferase)]
[MCCC1 MCCA] Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)
[fadD13 Rv3089] Long-chain-fatty-acid--CoA ligase FadD13 (EC 6.2.1.3) (Fatty acyl-CoA ligase) (FACL) (FACL13) (Fatty acyl-CoA synthetase) (ACS) (FACS) (Very-long-chain fatty-acyl-CoA synthetase) (ACSVL)
Bibliography :
[28081629] Punicalagin Pretreatment Attenuates Myocardial Ischemia-Reperfusion Injury via Activation of AMPK.
[25215643] A proteomics study of hyperhomocysteinemia injury of the hippocampal neurons using iTRAQ.
[20662380] The biotechnological potential of the extreme halophilic archaea Haloterrigena sp. H13 in xenobiotic metabolism using a comparative genomics approach.